✦ LIBER ✦

Methotrexate + low-dose prednisone for a hairy problem

Book ID: 120848827
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2006
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200615630-00028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose methotrexate therapy for hepato

Low-dose methotrexate therapy for hepatoblastoma

✍ Steven D. Weitman; Gregory J. Kato; Jerry L. Barbosa; Barton A. Kamen 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 145 KB

Metronomic cyclophosphamide and methotre

Metronomic cyclophosphamide and methotrexate for breast cancer: Enhanced efficacy by adding dalteparin and low-dose prednisone?

✍ Robert Buckman 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 284 KB

Low-dose cladribine for symptomatic hair

Low-dose cladribine for symptomatic hairy cell leukaemia

✍ Gunnar Juliusson; Rodica Lenkei; Geir Tjønnfjord; Dag Heldal; Jan Liliemark 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB

Low-dose methotrexate therapy for childh

Low-dose methotrexate therapy for childhood sarcoidosis

✍ Abraham Gedalia; Jose F. Molina; George S. Ellis Jr.; Wesley Galen; Cleveland Mo 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 462 KB

Low-dose methotrexate for the Sézary syn

Low-dose methotrexate for the Sézary syndrome

✍ Zackheim, Herschel S.; Epstein, Ervin H. 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 794 KB

Oral methotrexate and alternate-day pred

Oral methotrexate and alternate-day prednisone for low-risk langerhans cell histiocytosis

✍ Womer, Richard B. ;Anunciato, Kelly Raff ;Chehrenama, Mahan 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB

## Abstract Many treatments for low‐risk Langerhans cell histiocytosis (LCH) involve unpleasant side‐effects or risks of late effects. To provide treatment with minimal toxicity and no known risk of late effects, we have used oral alternate‐day prednisone (PDN, 40 mg/sq.m./day) and weekly methotrex